Table 1 Clinico-pathologic features of tumors in different groupsa.

From: T3 versus T4a staging challenges in deeply invasive colonic adenocarcinomas and correlation with clinical outcomes

Variables

Categories

Group 1

Group 2

Group 3

p value

Age (years)

Mean

70.0

68.2

67.5

 

Median

73.5

71

69

0.58b

Gender

Male

18 (47%)

23 (47%)

27 (42%)

 

Female

20 (53%)

26 (53%)

37 (58%)

0.83

Tumor size (cm)

Mean

5.80

5.12

4.61

 

Median

5.25

4.50

3.80

0.017b

Tumor grade

Low

32 (84%)

33 (67%)

54 (84%)

 

High

6 (16%)

16 (33%)

10 (16%)

0.06

Lymphovascular invasion

Absent

16 (42%)

27 (55%)

40 (62%)

 

Suspicious

4 (11%)

2 (4%)

7 (11%)

 

Present

18 (47%)

20 (41%)

17 (27%)

0.15

Large vessel invasion

Absent

34 (89%)

40 (82%)

62 (97%)

 

Present

4 (11%)

9 (18%)

2 (3%)

0.027

Tumor deposits

Absent

29 (76%)

36 (73%)

58 (91%)

 

Present

9 (24%)

13 (27%)

6 (9%)

0.043

Lymph node metastases

Mean

2.68

2.49

1.05

 

Median

0.50

1.00

0.00

0.012b

Metachronous distant metastases (including peritoneum)

Absent

25 (66%)

32 (65%)

57 (89%)

 

Present

13 (34%)

17 (35%)

7 (11%)

0.004

  1. aGroup 1—T4a colonic adenocarcinoma at the serosal surface; Group 2—Deeply invasive colonic adenocarcinoma ≤1 mm from the serosal surface; Group 3—T3 colonic adenocarcinoma >1 mm from the serosal surface.
  2. bKruskal–Wallis p value.